Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001606302-26-000002

Chief Executive Officer acquired 25,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
McMinn Rachel Chief Executive Officer 2026-02-20 Grant or award +25,900 1,347,659 D
Derivatives
McMinn Rachel Chief Executive Officer 2026-02-20 Grant or award · Stock Option (Right to Buy) +155,100 155,100 D
Loading xslF345X05/wk-form4_1771976903.xml…